Leaderboards/Neuroendocrine Tumor Research Advances

Neuroendocrine Tumor Research Advances

Last updated June 1, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Xuyi Yue
Nemours Children's Health System
80
2
Md. Faiyazuddin
Saveetha University
56
3
Steven D. Wexner
Cleveland Clinic Florida
53
4
Shunrong Ji
Fudan University Shanghai Cancer Center
51
5
Jay Burmeister
Wayne State University
51
6
Madson Quriroz Almeida
Universidade de São Paulo
51
7
Kaylie E Hughes
Lancashire Teaching Hospitals NHS Foundation Trust
50
8
Zuzanna Wójcik
Gdańsk Medical University
50
9
Benjamin H. Lok
University of Toronto
50
10
George Zogopoulos
McGill University Health Centre
50

Rising Stars Papers

Insufficient data

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Deborah Collyar
Advocates for Youth
99
2
Hanieh Karimi
Nemours Children's Health System
95
3
Roberta Modica
University of Naples Federico II
70
4
Mohd Sayeed Shaikh
Government Medical College
59
5
Victor Strassmann
Twitter (United States)
54
6
Namrata Vijayvergia
Unknown
51
7
Senjie Dai
Fudan University Shanghai Cancer Center
51
8
Eduardo C Lobato
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
51
9
Jianghong Cai
Macau University of Science and Technology
51
10
Dan-Dan LI
Unknown
50

Emerging Leaders Papers

Insufficient data

All-Time Leaders

The canon

All-Time Leaders Researchers

1
James C. Yao
The University of Texas MD Anderson Cancer Center
99
2
Dongmei Lin
Peking University
74
3
Takaaki Ito
Kumamoto University
69
4
Adam J. Olszewski
Memorial Hospital of Rhode Island
66
5
Hridayesh Prakash
Amity University
65
6
Jun Pang
Sun Yat-sen University
65
7
Mark A. Atkinson
University of Florida
64
8
Rakesh Kumar
All India Institute of Medical Sciences
64
9
L. Sylvia
University Hospitals of Cleveland
59
10
Fiona Blackhall
University of Manchester
59

All-Time Leaders Papers

1
Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes.
Journal of Clinical Investigation|1994
457 cit.
2
Population-Based Study of Islet Cell Carcinoma
Annals of Surgical Oncology|2007
338 cit.
3
Insulinoma-Associated Protein 1 Is a Crucial Regulator of Neuroendocrine Differentiation in Lung Cancer
American Journal Of Pathology|2015
140 cit.
4
Stat3 in Resident Macrophages as a Repressor Protein of Inflammatory Response
The Journal of Immunology|2005
111 cit.
5
Targeting N-Cadherin through Fibroblast Growth Factor Receptor-4: Distinct Pathogenetic and Therapeutic Implications
Molecular Endocrinology|2006
53 cit.
6
CRISPR screening identifies CDK12 as a conservative vulnerability of prostate cancer
Cell Death and Disease|2021
43 cit.
7
Sphingosine Kinase-1 (SphK-1) Regulates Mycobacterium smegmatis Infection in Macrophages
PLoS ONE|2010
33 cit.
8
Overexpression of nucleostemin contributes to an advanced malignant phenotype and a poor prognosis in oral squamous cell carcinoma
British Journal of Cancer|2014
28 cit.
9
The Tyrphostin Agent AG490 Prevents and Reverses Type 1 Diabetes in NOD Mice
PLoS ONE|2012
21 cit.
10
Expression of the melanoma-associated antigen is associated with progression of human thyroid cancer
Endocrine Related Cancer|2009
20 cit.

Reagents for Neuroendocrine Tumor Research Advances

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

Cell Signaling Technology

Histone H3 (D1H2) Rabbit Monoclonal Antibody (HRP Conjugate)

#12648$465
View Evidence →

⭐ Recommended

Best all-around

Cell Signaling Technology

Vemurafenib

Cited in 5 papers
#17531$66
View Evidence →Agilent/Dako

Synaptophysin

Cited in 5 papers
#M0776
View Evidence →Agilent/Dako

Monoclonal Mouse Anti-Human Ki-67 Antigen, Clone MIB-1

Cited in 5 papers
#M7240
View Evidence →

🌟 All-Time

Most validated

Cell Signaling Technology

COL3A1 Antibody

Cited in 13 papers
#30565$317
View Evidence →Agilent/Dako

Chromogranin-A (CHGA)

Cited in 12 papers
#M0869
View Evidence →Agilent/Dako

Polyclonal Rabbit Anti-Human Chromogranin A

Cited in 8 papers
#A0430
View Evidence →